Načítá se...
Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective
Clozapine is the only effective antipsychotic for treatment-resistant schizophrenia but remains widely under prescribed, at least in part due to its potential to cause agranulocytosis and neutropenia. In this article, we provide an overview of the current understanding of the genetics of clozapine-a...
Uloženo v:
| Vydáno v: | Pharmacogenomics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563116/ https://ncbi.nlm.nih.gov/pubmed/30767710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2018-0188 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|